page number/name of cvhis-files.com/lifkopdf/bhirot2019/פרמקותרפיה...

Alon Eisen, MD, FESC CV updated Oct 2018

1/17

CURRICULUM VITAE

Name: Alon Eisen MD, FESC Identity No.:027110667 Faculty/Dept: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv,

Israel/Cardiology Hospital/Dept: Department of Cardiology

Rabin Medical Center Beilinson Campus Petach Tikva 49100 Israel Phone No.:+972-3-9377111

Home Address: Hatzivoni 2 Moshav Ein Vered 40696 Mobile: +972-507302512

POB 372, Israel Email: [email protected]; [email protected]

Date & Place of Birth: December 20, 1973, Israel

Date of Arrival in Israel: ZAHAL (Israeli) 18/03/1992 17/03/1996 Military Service: (Enlisted) (Discharged) Rank: Major (Paratroopers)

Marital Status: Married + 3

A. EDUCATION

PERIODS OF STUDIES

1998-2001 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel B.Med.Sc. degree 2002-2005 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Subject: Medicine MD degree Title of Doctoral Dissertation: Coronary and aortic calcifications

inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--

mailto:[email protected]

mailto:[email protected]


2/17

Israeli spiral computed tomography substudy.

Supervisors: Ehud Schwammenthal; Yehuda Adler 21.08.2006: MD license no. 37797 2010 Board examinations Subject: Internal Medicine Specialist License No.:1-2083 2013 Board examinations Subject: Cardiology Specialist License- No. 1-3034

B. FURTHER STUDIES 2010 Post-graduate studies (CME), Sports Medicine, Sackler

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

C. ACADEMIC & PROFESSIONAL ACTIVITIES & ACHIEVEMENTS C.1. Academic Experience: 2007-2010 Lecturer, Nursing College, Meir Medical Center, Kfar Saba, Israel 2009-present Tutor to medical students (Internal Medicine and Cardiology

Programs: 6-year program, 4-year program, New York program), Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Meir Medical Center, Kfar Saba; Rabin Medical Center, Beilinson Campus, Petach Tikva; Israel

2010-2014 Lecturer, Dina Academic School of Nursing, Rabin Medical Center,

Beiinson Campus, Petach Tikva, Israel 2010-2014 Examiner, candidates for Medical School, Sackler Faculty of

Medicine, Tel Aviv University, Tel Aviv, Israel 2013-2016 Lecturer in Cardiology, Sackler Faculty of Medicine, Tel Aviv

University, Tel Aviv, Israel


3/17

2010-present Associate Writer and Examiner, Internal Medicine final examinations, 4th and 6th year medical students, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

2012-2014 Head and Coordinator, “Gesher Kal” – Preclinical Cardiology

Program, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

2012-2015 Head of “Israeli Cardiologists of Tomorrow” working group, Israel

Heart Society in association with the European Society of Cardiology

2015-2016 Preceptor and observer, Medicine students, Patient Doctor II

course, Harvard Medical School, Boston, USA. 2016-present Senior Lecturer in Cardiology, Sackler Faculty of Medicine, Tel

Aviv University, Tel Aviv, Israel 2018- Cardiology boards exam committee member, Israel Heart Society.

Head of step a. examination. 2018- Education and examinations committee, Sackler Faculty of

Medicine, Tel Aviv University, Tel Aviv, Israel. 2018- Research grants committee, Sackler Faculty of Medicine, Tel Aviv

University, Tel Aviv, Israel. C.2. Professional Experience: 2005-2006 Internship, Rabin Medical Center, Beilinson Campus, Petah Tikva,

Israel 2007-2010 Medical monitoring, Teva Pharmaceutical Industries Ltd., Netanya,

Israel 2007-2010 Resident, Department of Internal Medicine, Meir Medical Center,

Kfar Saba, Israel 2010-2014 Resident (Chief resident 2012-2014),Department of Cardiology,

Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel 2014- 2016 Research fellow, TIMI study group, Brigham Women's Hospital,

affiliated to Harvard Medical School, Boston, Massachusetts.


4/17

2016- Senior cardiologist, Intensive cardiac care and intermediate units, Cardiovascular division, Rabin Medical Center, Petah Tikva, Israel.

Courses 2011 Advanced Cardiac Life Support course 2012 GCP course (Certification in design, conduct and management of

clinical trials, Israel Medical Association 2013 Advanced Trauma Life Support course 2017 International Leadership program, American College of Cardiology 2017 Management course for physicians- Clalit health care

C3. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS 2008 Israel Heart Society Annual Congress, Tel Aviv, Israel (Poster presentation) 2009 European Society of Cardiology - EuroPRevent 2009, Stockholm,

Sweden (Poster presentation) 2011 European Society of Cardiology Congress, Paris, France (Poster

presentation) 2011 Israel Heart Society Annual Congress, Tel Aviv, Israel (2 Oral presentations, 1 Poster) 2012 European Society of Cardiology Heart Failure Congress, Belgrade

Serbia (3 Poster presentations) 2012 European Society of Cardiology Congress, Munich, Germany (2 Poster presentations) 2012 Israel Heart Society Annual Congress, Tel Aviv, Israel (3 Oral presentation, 2 Posters) 2013 American College of Cardiology Scientific Meeting - ACC.13, San

Francisco, USA (1 Poster presentation)


5/17

2013 Heart Rhythm Society Meeting, Denver, Colorado, USA (1 Moderated Poster)

2013 Israel Heart Society Annual Congress, Tel Aviv, Israel (2 Oral

presentations, 1 Poster, Active Participation in Cardiologists of tomorrow sessions)

2013 European Society of Cardiology Congress, Amsterdam,

Netherlands (1 Poster presentation) 2014 Israel Heart Society Annual Congress, Tel Aviv, Israel (1 Oral

presentation) 2014 European Society of Cardiology Congress, Barcelona, Spain (2

Oral presentations, 1 Poster). 2015 European Society of Cardiology Congress, London, England (2

Posters). 2015 Heart Rhythm Symposium, Kansas, USA (1 oral presentation) 2015 American Heart Association Congress, Orlando, USA (1 oral

presentation, 1 poster). 2016 American College of Cardiology Congress, Chicago, USA (2

posters). 2016 European Society of Cardiology Congress, Rome (1 LBCT oral

presentation; 1 featured research oral presentation) 2016 American Heart Association congress, New Orleans (1 poster) 2017

C4. MEMBERSHIP IN PROFESSIONAL SOCIETIES Israel Heart Society

European Society of Cardiology, FESC since November 2016

American College of Cardiology


6/17

D. DOCTURAL STUDENTS MENTORED BY CANDIDATE 2013-2015 Guy Topaz. Association between Red Cell Distribution Width and

Mortality after Cardiac Resynchronization Therapy. Sackler Faculty of Medicine. MD degree.

F. GRANTS and AWARDS 2008 Best scientific annual publication award, Israel Heart Society.

(Eisen A, Tenenbaum A, Koren-Morag N, Tanne D, Shemesh J, Imazio M, Fisman EZ, Motro M, Schwammenthal E, Adler Y. Calcification of the thoracic aorta as detected by spiral computed Tomography among stable angina pectoris patients: association With cardiovascular events and death. Circulation 2008 Sep 23;118(13):1328-34. . 2011 Young Investigator Grant (Effect of high dose statin pretreatment

on endothelial progenitor cells after PCI) Granted by Rabin Medical Center Total Amount: 10,000$ 2011 Research Grant and Fellowship Grant for Talent Management

Program, Clalit Health Services Granted by Clalit Health Services Total Amount: Research grant 10,000$. 2011 Attending grant for the ESC Annual Congress, 2011, Israel Heart

Society Granted by Israel Heart Society. Total Amount: 7,500 NIS. 2012 Best research abstract for trainees, Israel Heart Society ("Effect of high dose statin pretreatment on endothelial progenitor cells after PCI”). 2013 Clalit Research Institute Research program (Association Between normal kidney function and mortality and Cardiovascular morbidity). Granted by Clalit Health Services,Clalit research Institute


7/17

2013 Research scholarship (Effect of high dose statin pretreatment on

endothelial progenitor cells after PCI) Granted by Israel Heart Society Total Amount: 10,000 NIS. 2013 Attending grant for the ESC Annual Congress, 2013, Israel Heart

Society. Granted by Isreal Heart Society Total Amount: 7,500 NIS. 2014 The annual Daniel Shiran outstanding cardiology resident for 2013-2014, Israel Heart Society.

Granted by Israel Heart Society on April 2014. Total amount- 2000$.

2014 Excellent teacher award in pre-clinical cardiology course, Sackler faculty of medicine, Tel Aviv University, Tel Aviv, Israel.

2015 Young Investigator Cardiovascular Research Award (2nd place), Kansas City Heart Rhythm Symposium, July 2015.

2017 European Heart Rhythm Association educational grant. 2018 Young Investigator Grant- Osnat Itzhaki (Effect of PCSK9

inhibitors on endothelial progenitor cells) Granted by Rabin Medical Center Total amount- 7000$

SCIENTIFIC PUBLICATIONS

B.1. ORIGINAL ARTICLES

B.1. Articles Published 1. Eisen A, Tenenbaum A, Koren-Morag N, Tanne D, Shemesh J, Golan A,

Fisman EZ, Motro M, Schwammenthal E, Adler Y. Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy. Isr Med Assoc J 2007 Apr;9(4):277-80.

(MEDICINE, GENERAL & INTERNAL 91/154, IF 1.013, Cited 1 )


8/17

2. Iakobishvili Z, Eisen A, Porter A, Cohen N, Abramson E, Mager A, Shapira Y, Sagie A, Battler A, Hasdai D. Acute coronary syndromes in patients with prosthetic heart valves-a case-series. Acute Card Care 2008;10(3):148-51.

(No IF, Cited 1) 3. Eisen A, Tenenbaum A, Koren-Morag N, Tanne D, Shemesh J, Imazio M,

Fisman EZ, Motro M, Schwammenthal E, Adler Y. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation 2008 Sep 23;118(13):1328-34.

(CARDIAC & CARDIOVASCULAR SYSTEMS 3/123, Q1, IF 15.073, Cited 65) 4. Eisen A, Benderly M, Goldbourt U, Haim M.

Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease? Clin Cardiol 2013 Feb;36(2):110-6.

(CARDIAC & CARDIOVASCULAR SYSTEMS 52/123, IF 2.586, Cited 2) 5. Eisen A, Kornowski R, Vaduganathan M, Lev E, Vaknin-Assa H, Bental T,

Orvin K, Brosh D, Rechavia E, Battler A, Assali A. Retroperitoneal Bleeding after Cardiac Catheterization: A 7-Year Descriptive Single-Center Experience. Cardiology 2013 Jun 20;125(4):217-222.

(CARDIAC & CARDIOVASCULAR SYSTEMS 58/123, IF 2.177, Cited 2) 6. Eisen A, Nevzorov R, Goldenberg G, Kuznitz H, Porter A, Golovtziner G,

Strasberg B, Haim M. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study. Pacing Clin Electrophysiol 2013 Jul;36(7):872-7.

(ENGINEERING, BIOMEDICAL 56/76, IF 1.129, Cited 1) 7. Eisen A, Bental T, Assali A, Kornowski R, Lev EI.

Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention. J Thromb Thrombolysis 2013 Jan 24. [Epub ahead of print]

(HEMATOLOGY 44/68, IF 2.169, Cited 7) 8. Eisen A, Lev EI, Iakobishvili Z, Porter A, Brosh D, Hasdai D, Mager A.

Low plasma vitamin D levels and muscle related adverse events in statin users. IMAJ 01/2014; 16 (1): 42-5.

(MEDICINE, GENERAL & INTERNAL 91/154, IF 1.013, Cited 7)


9/17

9. Orvin K, Bental T, Eisen A, Vaknin-Assa H, Assali A, Lev EI, Brosh D, Kornowski R.

Fractional flow reserve application in everyday practice: adherence to clinical recommendations. Cardiovasc Diagn Ther July 2013; 3(3): 137-45. (No IF, Cited 0).

10. Levi A, Kornowski R, Vaduganathan M, Eisen A, Vaknin-Assa H, Abu-foul S,

Lev EI, Brosh D, Bental T, Assali A. Incidence, predictors and outcomes of failed primary percutaneous intervention: a 10- year contemporary experience. Coron Artery Dis. 2014 Mar;25(2):145-51 (CARDIAC & CARDIOVASCULAR SYSTEMS 79/123, IF 1.497, Cited 1)

11. Eisen A, Suleiman M, Strasberg B, Sela R, Rosenheck S, Freedberg NA, Geist

M,Ben-Zvi S, Goldenberg I, Glikson M, Haim M; Israeli working group of pacing and electrophysiology of the Israel Heart Society.

Renal dysfunction and clinical outcomes of patients undergoing ICD and CRTD implantation: data from the Israeli ICD registry. J Cardiovasc Electrophysiol. 2014 Sep;25(9):990-7. (CARDIAC & CARDIOVASCULAR SYSTEMS 43/123, Q2, IF 3.156, Cited 3)

12. Eisen A, Benderly M, Behar S, Goldbourt U, Haim M. Inflammation and future risk of symptomatic heart failure in patients with stable

coronary artery disease. Am Heart J. 2014 May;167(5):707-14. (CARDIAC & CARDIOVASCULAR SYSTEMS 23/123, Q1, IF 4.463, Cited 5)

13. Eisen A, Lerman-Shivek H, Perl L, Rechavia E, Leshem-Lev D, Zemer-

Wassercug N, Dadush O, Kazum S, Codner P, Kornowski R, Lev EI. Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor. J Thromb Thrombolysis. 2015 Jul;40(1):70-5. (HEMATOLOGY 44/68, Q3, IF 2.169, Cited 3)

14. Eisen A, Leshem-Lev D, Yavin H, Orvin K, Mager A, Rechavia E, Bental T,

Dadush O, Battler A, Kornowski R, Lev EI. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After

Percutaneous Coronary Intervention (HIPOCRATES Study). Cardiovasc Drugs Ther. 2015 Apr;29(2):129-35. (CARDIAC & CARDIOVASCULAR SYSTEMS 42/123, Q2, IF 3.189, Cited 0)

15. Orvin K, Eisen A, Goldenberg I, Gottlieb S, Kornowski R, Matetzky S,


10/17

Golovchiner G, Kuznietz J, Gavrielov-Yusim N, Segev A, Strasberg B, Haim M. Outcome of contemporary acute coronary syndrome complicated by ventricular

tachyarrhythmias. Europace. 2016; 18 (2): 219-26. (CARDIAC & CARDIOVASCULAR SYSTEMS 37/123, Q2, IF 3.670, Cited 0 )

16. Eisen A, Hoshen M, Balicer RD, Reges O, Rabi Y, Leibowitz M, Iakobishvili Z,

Hasdai D. Estimated Glomerular Filtration Rate Within the Normal or Mildly Impaired Range and Incident Cardiovascular Disease. Am J Med. 2015 Sep;128(9):1015-22. (MEDICINE, GENERAL & INTERNAL 18/154, Q1, IF

5.003, Cited 0) 17. Orvin K, Eisen A, Goldenberg I, Farkash A, Shlomo N, Gevrielov-Yusim N,

Iakobishvili Z, Hasdai D. The proxy of renal function that most accurately predicts short- and long-term

outcome after acute coronary syndrome. Am Heart J. 2015 May;169(5):702-712. (CARDIAC & CARDIOVASCULAR SYSTEMS 23/123, Q1, IF 4.463, Cited 1)

18. Topaz G, Haim M, Kusniec J, Kazum S, Goldenberg G, Golovchiner G,

Kornowski R, Strasberg B, Eisen A. Association between Red Cell Distribution Width and Mortality after Cardiac

Resynchronization Therapy. Isr Med Assoc J. 2015 Aug;17(8):505-9. (MEDICINE, GENERAL & INTERNAL 91/154, Q3, IF 1.013, Cited 1)

19. Bogdan S, Nof E, Eisen A, Sela R, Rosenheck S, Freedberg N, Geist M, Ben-

Zvi S, Haim M, Glikson M, Goldenberg I, Suleiman M; Israeli working group of pacing and electrophysiology of the Israeli Heart Society.

Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation. Am J Nephrol. 2015;42(4):295-304. (UROLOGY & NEPHROLOGY 22/78, Q2, IF 2.669, Cited 0)

20. Orvin K, Eisen A, Perl L, Zemer-Wassercug N, Codner P, Assali A, Vaknin-

Assa H, Lev EI, Kornowski R. Platelet reactivity in patients undergoing transcatheter aortic valve

implantation. J Thromb Thrombolysis. 2015 Dec 22. [Epub ahead of print] PubMed PMID: 26695072. (HEMATOLOGY 44/68, Q3, IF 2.169, Cited 0).

21. Eisen A, Giugliano RP, Ruff CT, Nordio F, Gogia HS, Awasty VR, Henderson

DA, Mercuri MF, Rutman H, Antman EM, Braunwald E.


11/17

Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial. American Heart Journal 2015; Volume 172 , 144 – 151; http://dx.doi.org/10.1016/j.ahj.2015.11.004 [Epub ahead of print] (CARDIAC & CARDIOVASCULAR SYSTEMS 23/123, Q1, IF 4.463, Cited 0)

22. Kazum S, Eisen A, Lev EI, Iakobishvili Z, Solodky A, Hasdai D, Kornowski R,

Mager A. Prevalence of Carotid Artery Disease among Ambulatory Patients with Coronary Artery Disease. Isr Med Assoc J 2016; 18:100-103. (MEDICINE, GENERAL & INTERNAL 91/154, Q3, IF 1.013, Cited 0)

--------------------------------------------------------------------------------------------------------------- 23. Eisen A, Cannon CP, Blazing MA, Bohula EA, Park JG, Murphy SA, White JA, Giugliano RP, Braunwald E; IMPROVE-IT (IMProved Reduction of Outcomes:

Vytorin Efficacy International Trial) Investigators. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial. Eur Heart J. 2016 Dec 21; 37(48):3576-3584. (CARDIAC & CARDIOVASCULAR SYSTEMS 3/123, Q1, IF 15.06, Cited 0)

24. Eisen A, Ruff CT, Braunwald E, Nordio F, Corbalán R, Dalby A, Dorobantu M, Mercuri M, Lanz H, Rutman H, Wiviott SD, Antman EM, Giugliano RP. Sudden

Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2016 Jul 8;5(7). (CARDIAC & CARDIOVASCULAR SYSTEMS 18/123, Q1, IF 5.12, Cited 0)

25. Eisen A, Bhatt DL, Steg GP, Eagle K, Goto S, Guo J, Smith S, Ohman E, Scirica BM. Angina and Future Cardiovascular Events in Stable Patients with Coronary Artery Disease: Insights from the REACH registry. J Am Heart Assoc. 2016 Sep 28;5(10). (CARDIAC & CARDIOVASCULAR SYSTEMS

18/123, Q1, IF 5.12, Cited 0) 26. Eisen A, Haim M, Hoshen M, Balicer RD, Reges O, Leibowitz M, Iakobishvili Z,

Hasdai D. Estimated glomerular filtration rate within the normal or mildly impaired range and incident non-valvular atrial fibrillation: Results from a population-based cohort study. Eur J Prev Cardiol. 2017 Jan;24 (2):213-222. (CARDIAC & CARDIOVASCULAR SYSTEMS , Q1, IF, Cited 0)

27. Eisen A, Bonaca MP, Jarolim P, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KA, Bohula EA, Murphy SA, Braunwald E,

Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic


12/17

Disease in the TRA 2°P - TIMI 50 Trial. Clin Chem. 2017 Jan;63 (1):307-315. (CARDIAC & CARDIOVASCULAR SYSTEMS , Q1, IF, Cited 0).

28. Eisen A, Cannon CP, Braunwald E, Steen DL, Zhou J, Goodrich EL, Im K,

Dalby AJ, Spinar J, Daga S, Lukas MA, O'Donoghue ML. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the

Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial. J Am Heart Assoc. 2017 Jan 11;6(1).

29. Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C, Chao

TF, Le Heuzey JY, Mercuri M, Rutman H, Antman EM, Giugliano RP. Digoxin

Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2017 Jun 30;6 (7).

30. Hammer Y, Bishara J, Eisen A, Iakobishvili Z, Kornowski R, Mager A.

Seasonal patterns of acute and recurrent idiopathic pericarditis. Clin Cardiol. 2017 Nov;40(11):1152-1155.

31. Eisen A, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price

MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Cangrelor compared with clopidogrel in patients with prior

myocardial infarction - Insights from the CHAMPION trials. Int J Cardiol. 2018

Jan 1;250:49-55. 32. Topaz G, Gharra W, Eisen A, Hershko AY, Shilo L, Beeri G, Kitay-Cohen Y,

Pereg D. Impaired renal function is associated with adverse outcomes in patients with chest pain discharged from internal medicine wards. Eur J Intern Med. 2018 Jul;53:57-61.

33. Nevzorov R, Porter A, Mostov S, Kazum S, Eisen A, Goldenberg G,

Iakobishvili Z, Kusniec J, Golovchiner G, Strasberg B, Haim M. Gender-Related Differences in Outcomes of Patients with Cardiac Resynchronization Therapy. Isr Med Assoc J. 2018 May;5 (20):311-315.

34. Eisen A, Porter A, Hoshen M, Balicer RD, Reges O, Rabi Y, Leibowitz M, Iakobishvili Z, Hasdai D. The association between eGFR in the normal or

mildly impaired range and incident cadiovascular disease: Age and sex analysis. Eur J Intern Med. 2018 Aug;54:70-75.

35. Levi A, Chezar-Azerrad C, Hasdai D, Beigel R, Gottlieb S, Eisen A, Shlomo N,

Goldenberg I, Landes U, Kornowski R, Iakobishvili Z. Impact of Self-Reported Family History of Premature Cardiovascular Disease on the Outcomes of Patients Hospitalized for Acute Coronary Syndrome (from the Acute Coronary


13/17

Syndrome Israel Survey [ACSIS] 2000 to 2013). Am J Cardiol. 2018 Sep 15;122(6):917-921.

36. HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med. 2017 Sep 28;377(13):1217-1227. 37. Hammer Y, Iakobishvili Z, Hasdai D, Goldenberg I, Shlomo N, Einhorn M, Bental T, Witberg G, Kornowski R, Eisen A. Guideline-recommended therapies and clinical outcomes accoeding to the risk for recurrent cardiovascular events after an acute coronary syndrome. J Am Heart Assoc 2018; Sep 18; 7 (18).

B.2. CASE REPORTS B.2. Case Reports Published 1. Eisen A, Dovrish Z, Hadari R, Lew S, Amital H.

Jaundice and acute liver failure as the first manifestation of acute myeloid leukemia. Isr Med Assoc J 2008 Oct;10(10):733-5.

(MEDICINE, GENERAL & INTERNAL 80/151, IF 0.978, Cited 2) 2. Goldenberg G, Eisen A, Weisenberg N, Amital H.

Giant left atrium. Isr Med Assoc J 2009 Oct;11(10):641.

(MEDICINE, GENERAL & INTERNAL 80/151, IF 0.978, Cited 0) 3. Kedar R, Eisen A, Dovrish Z, Hadari R, Lew S, Amital H.

Isolated coronary vasculitis as a cause of unexpected sudden death. Isr Med Assoc J 2009 Dec;11(12):769-70.

(MEDICINE, GENERAL & INTERNAL 80/151, IF 0.978, Cited 3) 4. Eisen A, Iakobishvilli Z, Orvin K, Hasdai D.

Large Pericardial Cyst in a Young Woman Presenting with Fever, Abdominal Pain and Diarrhea. Harefuah 2013 Sep; 152 (9): 518-9.

(No IF, Cited )


14/17

B.3. REVIEW ARTICLES B.3. Review Articles Published 1. Eisen A, Fisman EZ, Rubenfire M, Freimark D, McKechnie R, Tenenbaum A,

Motro M, Adler Y. Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis 2004 Feb;172(2):201-10.

(PERIPHERAL VASCULAR DISEASE 15/67, IF 3.706, Cited 80) 2. Eisen A, Schwammenthal E, Adler Y.

[Ischemic preconditioning of the heart]. Harefuah 2008 Feb;147(2):163-8, 181. (No IF, Cited ) 3. Eisen A, Arnson Y, Dovrish Z, Hadary R, Amital H.

Arrhythmias and conduction defects in rheumatological diseases--a comprehensive review. Semin Arthritis Rheum 2009 Dec;39(3):145-56.

(RHEUMATOLOGY 8/29, IF 3.806, Cited 11) 4. Arnson Y, Shoenfeld Y, Alon E, Amital H.

The antiphospholipid syndrome as a neurological disease. Semin Arthritis Rheum 2010 Oct;40(2):97-108.

(RHEUMATOLOGY 8/29, IF 3.806, Cited 2) 5. Goldshmid O, Dovorish Z, Zehavi T, Eisen A, Bar-Dayan Y, Amital H.

Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn's disease: case report and review of the literature. Rheumatol Int 2011 Apr;31(4):525-7.

(RHEUMATOLOGY 16/29, IF 2.214, Cited 2) 6. Eisen A, Shapira Y, Sagie A, Kornowski R.

Infective endocarditis in the transcatheter aortic valve replacement era: comprehensive review of a rare complication. Clin Cardiol 2012 Nov;35(11):E1-5.

(CARDIAC & CARDIOVASCULAR SYSTEMS 64/122, IF 1.834, Cited 17) 7. Eisen A, Ruff CT. Edoxaban in patients with atrial fibrillation. Ther Adv Cardiovasc Dis. 2015 Dec

16. pii: 1753944715622130. [Epub ahead of print]. PubMed PMID: 26680560. (PHARMACOLOGY 110/248, Q2, IF 2.13, Cited 0)


15/17

8. Eisen A, Giugliano RP. Antiplatelet and Anticoagulation Treatment in Patients With Non ST- Segment

Elevation Acute Coronary Syndrome: Comparison of the Updated North American and European Guidelines. Cardiol Rev. 2015 Jul 16. [Epub

ahead of print] PubMed PMID: 26186386. (CARDIAC & CARDIOVASCULAR SYSTEMS 55/123, Q2, IF 2.407, Cited 0 )

9. Eisen A, Bhatt DL. Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.

Nat Rev Cardiol. 2015 Aug;12(8):445-6. doi: 10.1038/nrcardio.2015.87. Epub 2015 Jun 9. PubMed PMID: 26054831. (CARDIAC & CARDIOVASCULAR SYSTEMS 5/123, Q1, IF 9.183, Cited 1)

10. Eisen A, Giugliano RP, Braunwald E. Updates on Acute Coronary Syndrome:

A Review. JAMA Cardiol. 2016 Jul 20. doi: 10.1001/jamacardio.2016.2049. [Epub ahead of print] (CARDIAC & CARDIOVASCULAR SYSTEMS, NO IMPACT FACTOR YET).

11. Eisen A, Giugliano RP. Advances in the field of PCSK9 inhibitors. Current Opinion in Cardiology. Accepted for publication, Sep 2016. (CARDIAC & CARDIOVASCULAR SYSTEMS 65/123, Q31, IF 2.15, Cited 0)

12. Eisen A, Bhatt DL. Optimal duration of dual antiplatelet therapy. Heart. Accepted for publication, Nov 2016. (CARDIAC & CARDIOVASCULAR SYSTEMS 15/123, Q1, IF 5.69, Cited 0)

C. CHAPTER IN BOOK

Eisen A, Amital H. Adult Still Disease, Diagnostic criteria in Autoimmune diseases 2008; pp. 25-30.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED

AS PROCEEDINGS and D. 3. ABSTRACTS 1. Eisen A, Tenenbaum A, Koren-Morag N, Tanne D, Shemesh J, Imazio M,

Fisman EZ, Motro M, Schwammenthal E, Adler Y.


16/17

Calcification of the thoracic aorta as detected by spiral CT among stable angina pectoris patients: Association with cardiovascular events and death.

- Israel Heart Society Annual congress, Tel Aviv, Israel, April 2008. - European Society of Cardiology – EuroPRevent Congress, Stockholm,

Sweden, 2009 2. Eisen A, Lev EI, Iakobishvili Z, Porter A, Brosh D, Hasdai D, Mager A. Plasma vitamin D levels and myopathic complications among statin users in

Israel. - European Society of Cardiology Congress, Paris, France, 2011 - Israel Heart Society Annual Congress, Tel Aviv, Israel, April 2011. 3. Eisen A, Nevzorov R, Goldenberg G, Kuznitz H, Porter A, Golovtziner G,

Strasberg B, Haim M. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year

follow-up study. - Israel Heart Society Annual congress, Tel Aviv Israel, April 2011 - European Society of Cardiology Heart Failure Congress, Belgrade Serbia,

2012 4. Eisen A, Nevzorov R, Porter A, Golovtziner G, Haim M, Strasberg B, Kuznitz

H. Quality of life of patients with atrial fibrillation after cardiac resynchronization

therapy. Israel Heart Society Annual congress, Tel Aviv, Israel, April 2011 5. Eisen A, Benderly M, Goldbourt U, Haim M. Is serum uric acid level an independent predictor of heart failure among

patients with coronary artery disease European Society of Cardiology Heart Failure Congress, Belgrade Serbia,

2012 6. Eisen A, Benderly M, Behar S, Goldbourt U, Haim M. Inflammation and future risk of heart failure in stable coronary artery disease

patients. European Society of Cardiology Heart Failure Congress, Belgrade Serbia,

2012 7. Eisen A, Bental T, Assali A, Kornowski R, Lev EI.

Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention.

European Society of Cardiology Heart Failure Congress, Munich, Germany, 2012

8. Eisen A, Leshem-Lev D, Orvin K, Ben-Gal T, Daddush O, Battler A, Lev EI. Effect of high dose statin pretreatment on endothelial progenitor cells after PCI.


17/17

- European Society of Cardiology Heart Failure Congress, Munich, Germany, 2012

- Israel Heart Society Annual congress, Tel Aviv, Israel, April 2012

9. Eisen A, Nevzorov R, Goldenberg G, Kuznitz H, Porter A, Golovtziner G,

Strasberg B, Haim M QRS width in CRT implantation – Its association with re-admissions and

mortality. Israel Heart Society Annual congress, Tel Aviv, Israel, April 2012 10. Eisen A, Orvin K, Iakobishvili Z, Hasdai D. Risk implications of 5 different formulas for renal function in patients with

NSTE-ACS. Israel Heart Society Annual congress, Tel Aviv, Israel, April 2012 11. Eisen A, Kornowski R, Vaduganathan M, Lev E, Vaknin-Assa H, Bental T,

Orvin K, Brosh D, Rechavia E, Battler A, Assali A. Retroperitoneal bleeding after cardiac catheterization – a single center 7-year report.

Israel Heart Society Annual congress, Tel Aviv, Israel, April 2012 12. Eisen A, Suleiman M, Strasberg B, Sela R, Rosenheck S, Freedberg N, Geist M, Ben-Zvi S, Goldenberg I, Gavrielov Yusim N, Glikson M, Haim M. Renal dysfunction and outcomes in patients undergoing ICD and CRTD

implantation – data form the Israeli ICD Registry. - Israel Heart Society Annual congress, Jerusalem, Israel, April 2013 - Heart Rhythm Society Meeting, Denver, Colorado, USA, 2013 13. Eisen A, Orvin K, Iakobishvili Z, Hasdai D. Early and late mortality among patients with renal dysfunction in acute

coronary syndromes. American College of Cardiology Scientific Meeting - ACC.13, San Francisco,

USA, 2013 14. Eisen A, Orvin K, Iakobishvili Z, Hasdai D. Early and late mortality among patients with renal dysfunction among patients

with non-ST elevation acute coronary syndrome. Israel Heart Society Annual congress, Jerusalem, Israel, April 2013 15. Topaz G, Haim M, Kuznitz H, Kazum S, Goldenberg G, Golovchiner G,

Strasberg B, Eisen A, Association between red cell distribution width and outcomes after CRT

implantation. - Israel Heart Society Annual congress, Jerusalem, Israel, April 2013 - Cardiostim, France, June 2013.


18/17

16. Eisen A, Orvin K, Iakobishvili Z, Hasdai Z. Mortality among patients with renal

dysfunction in non-ST elevation acute coronary syndromes. ESC Congress 2013, Amsterdam, Netherlands, August 2013.

17. Eisen A, Hoshen M, Porter A, Iakobishvili Z, Reges O, Rabi Y, Leibowitz M, Balicer R, Hasdai D. Age-gender interaction in the prediction of incident cardiovascular disease based on GFR in patients with CKD stages 1-2. - Israel Heart Society Annual Congress, Tel Aviv, Israel, April 2014. - European Society of Cardiology, Barcelona, Spain, August 2014. 18. Eisen A, Hoshen M, Porter A, Iakobishvili Z, Reges O, Rabi Y, Leibowitz M, Balicer R, Hasdai D. Worse renal function within the normal or mildly impaired range in different age

groups is a predictor of incident cardiovascular disease. European Society of Cardiology, Barcelona, Spain, August 2014.

19. Eisen A, Hoshen M, Porter A, Iakobishvili Z, Reges O, Rabi Y, Leibowitz M, Balicer R, Hasdai D. Worse renal function within the normal or mildly impaired range in different age

groups is a predictor of incident cardiovascular disease. European Society of Cardiology, Barcelona, Spain, August 2014.

20. Eisen A, Cannon CP, Braunwald E, Steen DL, Zhou J, Dalby AJ, Spinar J, Daga S, Lukas MA, O'Donoghue ML. Predictors of failure to use of a high potency statin regimen after an acute

coronary syndrome: insights fFrom the SOLID- TIMI 52 trial. European Society of Cardiology, London, England, 2015.

21. Eisen A, Haim M, Hoshen M, Balicer RD, Leibowitz M, Iakobishvili Z, Hasdai D. Estimated Glomerular Filtration Rate within the Normal or Mildly Impaired

Range and Incident Non-Valvular Atrial Fibrillation in the General Population. - European Society of Cardiology, London, England, 2015. - Kansas City Heart rhythm Symposium, USA, 2015.

22. Eisen A, Bonaca MP, Jarolim P, Scirica BM, Bohula EA, Murphy SA,

Braunwald E, Morrow DA. High Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease In the

TRA2°P- TIMI 50 trial. American Heart Association, Orlando, USA 2015.


19/17

23. Eisen A, Giugliano RP, Ruff CT, Nordio F, Gogia HS, Awasty VR, Henderson DA, Mercuri MF, Rutman H, Antman EM, Braunwald E. Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial.

American Heart Association, Orlando, USA, 2015. 24. Eisen A, Bonaca M, Scirica BM, Bohula EA, Murphy S, Braunwald E, Morrow

DA. Bleeding in stable patients with atherosclerotic disease- Insights from the TRA2P TIMI 50 trial. American College of Cardiology Congress, Chicago, USA, 2016.

25. Eisen A, Ruff CT, Nordio F, Corbalan R, Dalby A, Dorobantu M, Mercuri M,

Lanz H, Rutman H, Antman EA, Braunwald E, Giugliano RP. Sudden Cardiac Death in 21,105 Patients with Atrial Fibrillation- Insights from the ENGAGE AF- TIMI 48 trial. American College of Cardiology Congress, Chicago, USA, 2016.

26. Eisen A, Cannon CP, Blazing MA, Bohula EA, Park JG, Murphy SA, White JA, Giugliano RP, Braunwald E; IMPROVE-IT (IMProved Reduction of Outcomes:

Vytorin Efficacy International Trial) Investigators. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.

European Society of Cardiology, Rome, Italy, 2016. 27. Eisen A, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price

MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL. Cangrelor compared with clopidogrel in patients with prior myocardial infarction- insights from the CHAMPION trials.

European Society of Cardiology, Rome, Italy, 2016. 28. Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C,

Leheuzey JY, Mercuri M, Rutman H, Antman EA, Giugliano RP. Digoxin use and subsequent clinical outcomes in patients with atrial fibrillation without heart failure in the ENGAGE AF-TIMI 48 trial.

American Heart Association, New Orleans, USA, 2016.

G. OTHER PUBLICATIONS

Eisen A. Oral Anticoagulation Therapy After Radiofrequency Ablation of Atrial Fibrillation and the Risk of Thromboembolism and Serious Bleeding.


20/17

http://www.acc.org. May 18, 2015. Accessed March 15 2016 (ACC.org Clinical Topic Collection). http://www.acc.org/latest-in-cardiology/articles/2015/05/18/09/52/oral-anticoagulation-therapy-after-radiofrequency-ablation-of-atrial-fibrillation

Eisen A. Optimal Parenteral Antithrombotic Therapy for a Patient Admitted With NSTE-ACS. http://anticoagulation.cardiosource.org. November 19, 2014. Accessed March 15 2016 (ACC.org Clinical Topic Collection). http://anticoagulation.cardiosource.org/Case-Challeges/2014/11/Optimal-Parenteral-Antithrombotic-Therapy-NSTE-ACS.aspx

H. REVIEWER (International Journals):

Journal of thrombosis and thrombolysis Therapeutics advances in cardiovascular disease. Diabetes/Metabolism Research and Reviews European Heart Journal American Heart Journal American Journal of Cardiology

Languages: Hebrew, English, French (basic)

http://www.acc.org/latest-in-cardiology/articles/2015/05/18/09/52/oral-anticoagulation-therapy-after-radiofrequency-ablation-of-atrial-fibrillation



http://anticoagulation.cardiosource.org/Case-Challeges/2014/11/Optimal-Parenteral-Antithrombotic-Therapy-NSTE-ACS.aspx

http://anticoagulation.cardiosource.org/Case-Challeges/2014/11/Optimal-Parenteral-Antithrombotic-Therapy-NSTE-ACS.aspx

page number/name of cvhis-files.com/lifkopdf/bhirot2019/פרמקותרפיה...

Documents